本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

ENDRA Life Sciences Inc

6.13
-0.8700-12.43%
盤後6.130.00000.00%19:56 EDT
成交量:9.79萬
成交額:63.78萬
市值:461.47萬
市盈率:-0.36
高:7.17
開:6.73
低:6.13
收:7.00
52周最高:22.68
52周最低:2.90
股本:75.28萬
流通股本:75.27萬
量比:0.03
換手率:13.01%
股息:- -
股息率:- -
每股收益(TTM):-17.0082
每股收益(LYR):-56.9402
淨資產收益率:-167.48%
總資產收益率:-80.91%
市淨率:3.13
市盈率(LYR):-0.11

資料載入中...

2025/10/15

重要事件披露

Form 8-K/A - Current report: [Amend]
2025/10/15

重要事件披露

Form 8-K - Current report
2025/08/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/07/25

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/23

重要事件披露

Form 8-K - Current report
2025/07/16

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2025/07/09

重要事件披露

Form 8-K - Current report
2025/07/09

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2025/06/11

重要事件披露

Form 8-K - Current report
2025/05/30

重要事件披露

Form 8-K - Current report
2025/05/15

重要事件披露

Form 8-K - Current report
2025/05/15

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2025/04/05

[修訂]年度報告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2025/04/03

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/31

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/31

重要事件披露

Form 8-K - Current report
2024/11/22

重要事件披露

Form 8-K - Current report
2024/11/21

[修訂]季度報告

Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
2024/11/19

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/15

重要事件披露

Form 8-K - Current report